Cell lines, reagents, and supplies

Ended Purchase Order Awarded Last action

Contract number
W91YTZ17P2035
Awardee
Awarding agency
Obligated
$105,158

Award facts

Opportunity
  • W91YTZ17T0383 Solicitation number
  • In-Vitro Cells Award Notice · Posted Sep 19, 2017
Contract value 100% obligated
$105,158.16 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fort Gordon, GA 30905, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · Cell lines, reagents, and supplies ROF FY18 1 year contract $105,158
Original award $0

About this award

This is a firm fixed-price purchase order contract awarded by the Department of the Army Medical Command to Diagnostic Hybrids Inc., a subsidiary of Quidel Corp, a manufacturer of medical diagnostics and supplies. The $105,158.16 contract is for the provision of cell lines, reagents, and supplies, and is set aside for small businesses. Quidel Corp is an established federal contractor, primarily focused on providing COVID-19 test kits and other medical equipment and supplies to support pandemic response efforts across various government agencies.

Quick answers

Who was awarded contract W91YTZ17P2035?

W91YTZ17P2035 was awarded to Diagnostic Hybrids Inc. by Medical Command (Department of the Army) on October 1, 2017.

How much is contract W91YTZ17P2035 worth?

The government has obligated $105,158 on W91YTZ17P2035.

Was contract W91YTZ17P2035 competed?

The extent of competition for W91YTZ17P2035 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award